U.S. Markets open in 6 hrs 54 mins

BioCryst Pharmaceuticals, Inc. (BCRX)

NASDAQ Global Select - NASDAQ Global Select Delayed Price. Currency in USD
Add to watchlist
4.21+0.11 (+2.68%)
At close: 4:00PM EDT
People also watch
NVAXHEBVICLARRYAGEN
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue26,35348,25713,608
Cost of Revenue2,2971,3681
Gross Profit24,05646,88913,607
Operating Expenses
Research Development61,00872,75851,796
Selling General and Administrative11,25313,0477,461
Non Recurring402528121
Others---
Total Operating Expenses---
Operating Income or Loss-48,607-39,444-45,771
Income from Continuing Operations
Total Other Income/Expenses Net-501,6255,580
Earnings Before Interest and Taxes-48,657-37,819-40,191
Interest Expense6,4875,2004,998
Income Before Tax-55,144-43,019-45,189
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-55,144-43,019-45,189
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-55,144-43,019-45,189
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-55,144-43,019-45,189